Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system combines ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A novel mapping system to identify drivers of atrial fibrillation beyond the pulmonary vein was ...

First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...

NATICK, Mass., Boston Scientific Corporation completed a first-in-human clinical trial utilizing the IntellaTip MiFi™ XP Ablation Catheter for the treatment of type 1 atrial flutter, an arrhythmia ...

BURLINGTON, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- CoreMap today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to extend ...

Over the past 5 years, catheter ablation of atrial fibrillation (AF) has evolved from an experimental procedure to one that is performed in most large medical centers throughout the world. The rapid ...

Medtronic plc, a global leader in healthcare technology, announced the United States Food and Drug Administration (FDA) has approval of the Affera Mapping and Ablation System with Sphere-9 catheter, ...